Vical in Medical Technology

Vical Pandemic Influenza Vaccines Achieve T-Cell Responses and Cross-Clade Reactivity in Humans

... LAS VEGAS, Dec. 11 /PRNewswire-FirstCall/ -- vical Incorporated (Nasdaq: VICL ) today announced tha...uable subjects in the trial's higher dose cohorts. vical researchers presented the expanded data, as well a...ich a vaccine had not yet been developed. vical had previously reported that the monovalent vaccin...

SARS Vaccine Achieves Neutralizing Responses in First U.S. Human Trial

... SAN DIEGO, Dec. 9 /PRNewswire-FirstCall/ -- vical Incorporated (Nasdaq: VICL ) today announced tha...y faster development and production. About vical vical researches and develops biopharmaceutical products...

Vical Signs Binding Letter of Intent for Sales and Marketing of Allovectin-7(R) in Turkey

... SAN DIEGO, Dec. 3 /PRNewswire-FirstCall/ -- vical Incorporated (Nasdaq: VICL ) today announced an ... regulatory approvals for the territory and to pay vical upfront and milestone payments plus a specified tr... against both local and distant metastatic tumors. vical conducted a large Phase 2 trial evaluating Allovec...

Vical Receives Milestone Payment from Merck & Co., Inc. Triggered by Planned Initiation of Investigational Cancer DNA Vaccine Trial

... SAN DIEGO, Dec. 1 /PRNewswire-FirstCall/ -- vical Incorporated (Nasdaq: VICL ) announced today the...ur technology in the cancer area." About vical vical researches and develops biopharmaceutical products...

Vical Completes Enrollment and Reports Positive Interim Data in CMV Vaccine Phase 2 Trial

... SAN DIEGO, Nov. 12 /PRNewswire-FirstCall/ -- vical Incorporated (Nasdaq: VICL ) announced today that...d solid organ transplant patients. About Vical vical researches and develops biopharmaceutical products...ant unmet medical needs. Additional information on vical is available at http://www.vical.com . This pre...

U.S. Navy and U.S. Army to Develop Dengue DNA Vaccine Formulated With Vical's Vaxfectin(R) Adjuvant

... SAN DIEGO, Nov. 6 /PRNewswire-FirstCall/ -- vical Incorporated (Nasdaq: VICL) today announced that t...accine technologies and adjuvants. About Vical vical researches and develops biopharmaceutical products...ant unmet medical needs. Additional information on vical is available at http://www.vical.com . This pre...

Vical Expands Applications of Vaxfectin(R) Adjuvant for Infectious Disease and Cancer Vaccines; 80% to 100% of High-Dose Responders in H5N1 Clinical Trials Still Responding at 6 Months

... LYON, France, Oct. 8 /PRNewswire/ -- vical Incorporated (Nasdaq: VICL ) today is presenting ...ells. Vaxfectin(R)-formulated Protein Vaccines vical has previously reported that data from studies in ... Pandemic Influenza Vaccine Phase 1 Trial Update vical reported in July that the company's Vaxfectin(R)-f...

Karolinska Institutet to Test Vical's Vaxfectin(R) Adjuvant With Preventive Vaccine against HIV Under Sponsorship of Swedish Institute for Infectious Disease Control

... SAN DIEGO, Aug. 19 /PRNewswire-FirstCall/ -- vical Incorporated (Nasdaq: VICL ) today announced a re... About Vaxfectin(R) Vaxfectin(R) was designed by vical to increase the immune response to DNA vaccines. V...st infectious diseases and cancer. About Vical vical researches and develops biopharmaceutical products...

Karolinska Institute to Test Vical's Vaxfectin(R) Adjuvant with Preventive Vaccine against HIV Under Sponsorship of Swedish Institute for Infectious Disease Control

... SAN DIEGO, Aug. 19 /PRNewswire-FirstCall/ -- vical Incorporated (Nasdaq: VICL ) today announced a re... About Vaxfectin(R) Vaxfectin(R) was designed by vical to increase the immune response to DNA vaccines. V...st infectious diseases and cancer. About Vical vical researches and develops biopharmaceutical products...

Vical Announces Breakthrough for Pandemic Influenza DNA Vaccines With Preliminary Human Data

... SAN DIEGO, July 17 /PRNewswire-FirstCall/ -- vical Incorporated (Nasdaq: VICL ) today announced a br...nificant safety issues were observed at any of the vical vaccine doses tested. These results support furthe...-free injection. "These results are important to vical for three reasons," added Mr. Samant. "First, they...

Vical Advances RapidResponse(TM) DNA Vaccine Platform Under $6 Million Grant from NIH

... SAN DIEGO, June 25 /PRNewswire-FirstCall/ -- vical Incorporated (Nasdaq: VICL ) today announced that...ired by the bacteria in the manufacturing process. vical holds patents in the United States and in other ke... commercial realization in humans. About Vical vical researches and develops biopharmaceutical products...

Vical Receives $6.3 Million Payment for Continued Funding of Allovectin-7(R) Phase 3 Trial

... SAN DIEGO, June 12 /PRNewswire-FirstCall/ -- vical Incorporated (Nasdaq: VICL ) today announced the ... a series of cash payments and equity investments, vical has received $15.3 million to date of the $22.6 million total committed by AnGes. vical is conducting the Allovectin-7(R) Immunotherapeuti...

Promise of Vical's CMV Vaccine Noted by Independent Experts

...ovirus (CMV) said the vaccine under development by vical Incorporated (Nasdaq: VICL ), at the optimal dose...d solid organ transplant patients. About Vical vical researches and develops biopharmaceutical products...ant unmet medical needs. Additional information on vical is available at http://www.vical.com . This pre...

Vical Promotes Melanoma Awareness Month With Allovectin-7(R) Video Report

... SAN DIEGO, April 23 /PRNewswire-FirstCall/ -- vical Incorporated (Nasdaq: VICL ) today announced the ... against both local and distant metastatic tumors. vical conducted a large Phase 2 trial evaluating Allovec...Administration (FDA) in an End-of-Phase 2 meeting, vical successfully completed a Special Protocol Assessme...

Vical Receives NIH Grant for an Immunotherapeutic Herpes DNA Vaccine; Herpes Experts at University of Washington and University of Texas to Conduct Preclinical Development

...SAN DIEGO, April 3, 2008 /PRNewswire-FirstCall/ -- vical Incorporated (Nasdaq: VICL ) today announced that...STTR grant supplements the $0.3 million awarded to vical in 2005 for the HSV-2 vaccine program under a Phas...ion annually in the United States. About Vical vical researches and develops biopharmaceutical products...

Vical Receives Payment from AnGes MG for Allovectin-7(R) Phase 3 Pivotal Trial

... SAN DIEGO, Jan. 17 /PRNewswire-FirstCall/ -- vical Incorporated (Nasdaq: VICL ) today announced the ...sales in the United States and European countries. vical is conducting the trial in accordance with a Speci...ial expenses as they are incurred. About Vical vical researches and develops biopharmaceutical products...

Interim Safety Data Favorable for Vical's Phase 2 Trial of DNA Vaccine Against CMV

... SAN DIEGO, Oct. 17 /PRNewswire-FirstCall/ -- vical Incorporated (Nasdaq: VICL ) today announced that...splant and solid organ transplant patients. About vical vical researches and develops biopharmaceutical products...

Vical Demonstrates Dose-sparing of Protein-based H5N1 Influenza Vaccine With Vaxfectin(TM) Adjuvant

... LYON, France, Oct. 9 /PRNewswire-FirstCall/ -- vical Incorporated (Nasdaq: VICL ) today announced that...s related to the vaccination were observed. About vical vical researches and develops biopharmaceutical products...

Vical Licensee Sanofi-aventis Initiates Phase 3 Trial to Reduce Amputations

...wswire-FirstCall/ -- Sanofi-aventis, a licensee of vical Incorporated (Nasdaq: VICL ), announced on Monday...tical limb ischemia is currently available. About vical vical researches and develops biopharmaceutical products...

Vical Begins Phase 1 Trial of DNA Vaccine Against H5N1 Pandemic Influenza

... SAN DIEGO, Aug. 28 /PRNewswire-FirstCall/ -- vical Incorporated (Nasdaq: VICL ) today announced the ... inactivated influenza vaccine in animals." About vical vical researches and develops biopharmaceutical products...

Multiple NIH Phase 2 HIV Vaccine Trials Using Vical's Technology Produce Encouraging Results

... SEATTLE, Aug. 22 /PRNewswire-FirstCall/ -- vical Incorporated (Nasdaq: VICL) announced today that r...manufactured the adenoviral vector vaccine. About vical vical researches and develops biopharmaceutical products...

Vical Reports Second Quarter 2007 Financial Results, Allowance of Pandemic Influenza IND and Other Advances in Product Development Programs

... SAN DIEGO, Aug. 7 /PRNewswire-FirstCall/ -- vical Incorporated (Nasdaq: VICL) today reported financi...equity investments, of $27 million to $32 million. vical had cash and investments of $82 million at June 30, 2007. Pandemic Influenza IND Allowed -- vical has received notification of Investigational New D...

Vical's Vaxfectin Adjuvant Achieves Dose-Sparing Effect With Seasonal Influenza Vaccine

...very 2007 meeting (San Francisco, April 9 - 11). vical is developing its own Vaxfectin(TM)-formulated DNA...expected to begin in the second half of 2007. vical tested the Vaxfectin(TM) adjuvant with Fluzone(R) ...ls tested in mice. Vaxfectin(TM) was designed by vical to increase the immune response to DNA vaccines, a...

Vical's Vaxfectin Adjuvant With Needle-free Delivery Enhances DNA Vaccine Performance; Yields Antibody Responses Comparable to Electroporation Without Tolerability Issues

...comparable production of gB-specific antibodies. vical research scientist Jukka Hartikka, Ph.D., presente...by Vical's licensee, Merck & Co., Inc. About vical vical researches and develops biopharmaceutical products...

Vaxfectin-formulated Measles DNA Vaccine Elicits Long-term Protection and Sterilizing Immunity in Nonhuman Primates

...t severe among those who are malnourished. About vical vical researches and develops biopharmaceutical products...ant unmet medical needs. Additional information on vical is available at vical technology to deliver a gene encoding Hepatocyte G...lopment by carefully following the safety. About vical vical researches and develops biopharmaceutical products...